Publications by authors named "M Danieli"
Background: The role of prophylactic primary tumor resection (PTR) in patients with small intestinal neuroendocrine tumors (SI-NETs) and unresectable liver metastases is a matter of debate.
Objective: We aimed to evaluate outcomes in patients with SI-NETs who underwent PTR, according to the presence of metastasis and symptoms from primary.
Material And Methods: Data from patients who underwent PTR for SI-NETs from a single referral center (2007-2023) were prospectively collected.
Intravenous immunoglobulin (IVIg) is a medical preparation used as replacement therapy for patients with immunodeficiencies. Over time, IVIg's anti-inflammatory and immunomodulatory effects have been recognized, which have led to the approval of this therapy in the treatment of various pathologies, such as Kawasaki disease, immune thrombocytopenia, and Guillain-Barré syndrome. There are numerous studies in the literature regarding the off-label use of IVIg in the treatment of autoimmune diseases (e.
View Article and Find Full Text PDFArticle Synopsis
- Systemic lupus erythematosus (SLE) is an autoimmune disease affecting multiple organs, with recent studies highlighting the roles of oxidative stress and gut microbiota in its development.
- Oxidative stress leads to harmful reactions in cells, while imbalances in gut bacteria (dysbiosis) are linked to SLE onset and worsening symptoms.
- Intravenous immunoglobulins (IVIg) show promise as a treatment by reducing oxidative stress and restoring gut health, suggesting that targeting these factors could improve SLE management and outcomes.